Funding profile · Consumer relationship wellness

Agapé

A Rochester relationship app with one federal securities filing, a small venture-development investor, and no capital raise on record since 2021. Here is what the filing shows, and what it does not.

$1.77MSold of $2.07M offered, sole Form D on file (Jul 2021)
14Investors on that filing, about $127K average
$125KLaunch NY follow-on investment, Q3 2021
2018Year of incorporation, Delaware, per the filing

Data as of September 25, 2026. Company-reported figures are labeled.

Rounds at a glance

When Round Amount Investors Source
By 2021 Launch NY, initial investment Not disclosed Launch NY nonprofit Seed Fund and for-profit LP Fund Independent
2021, Summer batch Y Combinator Not disclosed Y Combinator Independent
First sale Jul 2, 2021 Equity offering $1,773,234 sold of $2,068,238 offered 14 investors Form D
Q3 2021 Launch NY, follow-on investment $125,000 Nonprofit Seed Fund and for-profit LP Fund Independent

What the filings show

Agape Wellness Inc. · Form D · filed Jul 19, 2021

First sale
Jul 2, 2021
Offered
$2,068,238 equity
Sold
$1,773,234 · $295,004 remaining
Investors
14 · average about $126,660
Exemption
Rule 506(b)
Related persons
Khadesha Okwudili (executive officer, director, promoter)
Filing
SEC EDGAR, CIK 0001873449

Reading the filings

  1. One filing covers the company’s entire SEC record.Agape Wellness Inc. has filed a single Form D, in July 2021. Nothing on EDGAR updates the $295,004 gap between what was offered and what had sold at the time of filing, and no later Form D appears under this name.
  2. Launch NY’s follow-on lands inside the filing window.The Form D’s first sale date is July 2, 2021. Rochester Business Journal reported Launch NY’s $125,000 follow-on investment as part of its third-quarter 2021 activity, the same window. At $125,000 against 14 investors averaging about $126,660 each, the amount is consistent with one investor among several, not the bulk of the round.
  3. The filing does not name Ronald Rogge.Only Khadesha Okwudili is listed as a related person, as CEO, director and promoter. Press coverage and the company’s own published research describe Rogge as a co-founder and Chief Research Officer, and he is a named author, alongside Okwudili, on both of the company’s peer-reviewed papers.
  4. The issuer carries two names.The filing lists the issuer as Agape Wellness Inc. and also shows “Agape App, Inc.” The company’s app, website and press coverage all use Agapé or Agapé Wellness Inc.
  5. No federal research money on record.Unlike some health-adjacent startups, this review found no NSF or NIH award tied to Agapé or Agape Wellness Inc. Its two published studies were run and authored in-house, with Rogge’s University of Rochester appointment providing the academic affiliation.
  6. Initial Launch NY amount is not on record.Rochester Business Journal describes the $125,000 as a “follow-on” investment, which implies an earlier Launch NY check, but this review found no report stating that earlier amount.

Commercial signals

Signal Detail Source type
Users More than 2 million, company reported and repeated by the University of Rochester. Company-stated
Google Play downloads 500,000-plus, about 9,500 reviews. App store data
Employees 6, per Fundraising Fox; a separate aggregator, Extruct AI, lists 51 to 200. Neither is a primary source, and the two do not agree. Unverified, conflicting
Product expansion Buffalo Business First reported in April 2023 that Agapé planned a new app version and a business-focused product; this review could not obtain the full article or confirm the product launched. Independent
Registered address SEC filing lists 300 Hylan Drive, Rochester, NY. App store listings give a New York City mailing address for the developer. Public record

What to watch

  • Any new Form D. None has been filed since July 2021, despite continued user growth reported through 2026.
  • A primary source for headcount, since the two aggregator estimates on record are far apart.
  • Whether the business-focused product referenced in 2023 reporting has launched, and under what terms.
  • Whether Launch NY or another investor discloses the initial, pre-follow-on investment amount.

The Agapé story on Healthcare DiscoveryHealthcare Discovery

Related companies

  • Measured: Shared investor: Lp Fund. A New York telehealth subscription that routes patients either to branded GLP-1 medicines through insurance or to compounded copies shipped to the door
  • Maia: Also in Consumer Health and Wellness. A mobile app that chats and talks with couples together, pitched as an always on stand in for inaccessible couples therapy
  • Reframe: Also in Consumer Health and Wellness. A subscription app from Atlanta that helps people cut back on or quit drinking, built on habit change rather than treatment
  • Deep Meditate: Also in Consumer Health and Wellness. A meditation, music and sleep app that grew past half a million downloads on word of mouth, went through Y Combinator's Winter 2020 batch, and has left conflicting paper

Sources

  1. Public recordForm D, Agape Wellness Inc.SEC EDGAR · filed Jul 19, 2021
  2. Public recordEDGAR company search, Agape Wellness Inc., CIK 0001873449SEC EDGAR
  3. IndependentIryss, Agape receive funding from Launch NYRochester Business Journal, Kevin Oklobzija · Nov 3, 2021
  4. IndependentStartup Agape to launch new version of its app, grow business productBuffalo Business First, Lian Bunny · Apr 11, 2023
  5. IndependentAgapé company profile, YC S21, founders and investorsFundraising Fox · accessed Sep 2026
  6. IndependentAgapé company profile, funding analysisExtruct AI · accessed Sep 2026
  7. Public recordConnection at your fingertips: A first look at the Agapé app’s contributions to healthy relationshipsJournal of Family Psychology, Rogge, Macri, Okwudili · Nov 20, 2023
  8. CompanyAgapé company profileY Combinator · accessed Sep 2026
  9. App store dataAgapé: Feel Close When Apart, App Store listingApple App Store · accessed Sep 2026
  10. App store dataAgapé: Feel Close When Apart, Google Play listingGoogle Play · accessed Sep 2026

Compiled from SEC public records and published reports as of September 25, 2026. Form D notices report offerings under Regulation D, and amounts reflect the filing date and may not capture later sales. Healthcare Venture Capital Fund holds no position in Agapé. This page is not an offer to sell or a recommendation to buy any security.